Emerging therapeutic agents for advanced non-small cell lung cancer

Advanced non-small cell lung cancer (NSCLC) is the most common type of lung cancer, with a poor prognosis and no known cure. Survival time is often short because of limited treatment options. Recent advances in targeted therapy and immunotherapy have changed the landscape for the treatment of advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ruqin, Manochakian, Rami, James, Lauren, Azzouqa, Abdel-Ghani, Shi, Huashan, Zhang, Yan, Zhao, Yujie, Zhou, Kexun, Lou, Yanyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245927/
https://www.ncbi.nlm.nih.gov/pubmed/32448366
http://dx.doi.org/10.1186/s13045-020-00881-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245927/
https://www.ncbi.nlm.nih.gov/pubmed/32448366
http://dx.doi.org/10.1186/s13045-020-00881-7

Ejemplares similares